Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ala-Gln in Peritoneal Dialysis
NCT01353638Phase 2Terminated
- Start
- Apr 2011
- Primary completion
- Mar 2012
- Countries
- 1
01
Overview
A Phase 2 trial of alanyl glutamine in end stage renal disease (ESRD). Started Apr 2011; status: terminated.
02
Drugs
alanyl glutamine
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01353638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01353638.